What is TG Therapeutics's net debt?

TG Therapeutics (TGTX) reported net debt of $311.35M in Q1 2026.

How has TG Therapeutics's net debt changed year-over-year?

TG Therapeutics's net debt increased by 156.1% year-over-year, from $121.57M to $311.35M.

What is the long-term trend for TG Therapeutics's net debt?

Over 5 years (2020 to 2025), TG Therapeutics's net debt has grown at a -19.3% compound annual growth rate (CAGR), from -$511.46M to $174.56M.

TG Therapeutics TGTX Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

LPL Financial HoldingsLPLA

$7.18B+26.3%

Ball CorporationBALL

3.4×-0.7×

Waste ConnectionsWCN

3.2×—

Agilent TechnologiesA

0.9×-0.3×

EntegrisENTG

3.9×-0.1×

IlluminaILMN

0.9×—

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

$753.6Mtotal debt−$442.2Mcash and equivalents=$311.35M

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's net debt?: TG Therapeutics (TGTX) reported net debt of $311.35M in Q1 2026.
How has TG Therapeutics's net debt changed year-over-year?: TG Therapeutics's net debt increased by 156.1% year-over-year, from $121.57M to $311.35M.
What is the long-term trend for TG Therapeutics's net debt?: Over 5 years (2020 to 2025), TG Therapeutics's net debt has grown at a -19.3% compound annual growth rate (CAGR), from -$511.46M to $174.56M.